NCT03631667View on ClinicalTrials.gov

Ultralow Dose PAH Binary Mixture Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 1, 2024

Study Completion Date

February 1, 2024

Conditions
Environmental Exposure
Interventions
DRUG

[14C]-benzo[a]pyrene

Oral micro-dose (50 ng) (5.4 nCi)

DRUG

[14C]-benzo[a]pyrene plus phenanthrene

Oral micro-dose of 50 ng (5.4 nCi) \[14C\]-benzo\[a\]pyrene plus 1250 ng phenanthrene

Trial Locations (1)

97331

Oregon State University, Corvallis

All Listed Sponsors
collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

collaborator

Lawrence Livermore National Laboratory

OTHER

collaborator

Pacific Northwest National Laboratory

FED

lead

Oregon State University

OTHER

NCT03631667 - Ultralow Dose PAH Binary Mixture Study | Biotech Hunter | Biotech Hunter